Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
369
datasets available to search
ShareScore release 0.9.0
Dataset results
369 results for “adalimumab”
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
ClinicalTrials.gov study NCT03828019. IPD Sharing: YES. Countries: 3. Publications: 1.
Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)
ClinicalTrials.gov study NCT02332590. IPD Sharing: YES. Countries: 15. Publications: 12.
Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)
ClinicalTrials.gov study NCT03259074. IPD Sharing: YES. Countries: 29. Publications: 2.
Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis
ClinicalTrials.gov study NCT02745080. IPD Sharing: YES. Countries: 26. Publications: 2.
Blood Cell Transcriptomics and Proteomics of Axial Spondyloarthritis patients undergoing adalimumab treatment
<p>This study aims at identifying molecular biomarkers differentiating good responders and non-responders to treatment with TNF inhibitors (TNFi), among patients with axial spondyloarthritis (axSpA). Publication: <em>Biomolecules</em> <strong>2024</strong>, <em>14</em>(3), 382; <a href="https://doi.org/10.3390/biom14030382">https://doi.org/10.3390/biom14030382</a></p>
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT02137226. IPD Sharing: Not stated. Countries: 15. Publications: 6.
Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT01970475. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT02019472. IPD Sharing: Not stated. Countries: 16. Publications: 1.
Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa
ClinicalTrials.gov study NCT00918255. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
ClinicalTrials.gov study NCT00195663. IPD Sharing: Not stated. Countries: 19. Publications: 12.
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
ClinicalTrials.gov study NCT02016105. IPD Sharing: UNDECIDED. Countries: 4. Publications: 2.
Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
ClinicalTrials.gov study NCT00420927. IPD Sharing: Not stated. Countries: 21. Publications: 6.
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT00409682. IPD Sharing: Not stated. Countries: 8. Publications: 3.
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
ClinicalTrials.gov study NCT02497469. IPD Sharing: YES. Countries: 34. Publications: 3.
Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.
ClinicalTrials.gov study NCT00195702. IPD Sharing: Not stated. Countries: 2. Publications: 7.
Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
ClinicalTrials.gov study NCT00195715. IPD Sharing: Not stated. Countries: 15. Publications: 3.
Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
ClinicalTrials.gov study NCT00409617. IPD Sharing: Not stated. Countries: 17. Publications: 1.
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02065557. IPD Sharing: YES. Countries: 14. Publications: 1.
Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing
ClinicalTrials.gov study NCT00647270. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01970488. IPD Sharing: Not stated. Countries: 3. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.